Another mechanism involves the inhibition of CD8+ T cell migration to tumor beds by TGF-β-mediated silencing of the gene encoding C-X-C chemokine receptor 3 (CXCR3) [38]. The gene discussed is TGFB1; the disease is neoplasm.